Welcome to our dedicated page for SBC Medical Group Holdings Incorporated SEC filings (Ticker: SBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how many cosmetic clinics SBC Medical Group Holdings Inc adds each quarter—or when its surgeons buy shares—often means digging through hundreds of pages. Revenue from franchise management fees, equipment procurement, and marketing support is spread across complex notes that few have time to decode.
Stock Titan’s AI solves that problem in seconds. Our platform ingests every SBC Medical Group Holdings filing the moment it hits EDGAR and produces plain-English highlights. Need the SBC Medical Group Holdings insider trading Form 4 transactions for yesterday? They’re already summarized. Curious about cost trends in the latest SBC Medical Group Holdings quarterly earnings report 10-Q filing? We flag the key metrics, clinic counts, and regulatory updates automatically.
All major document types are covered in real time:
- Form 4 insider deals—see SBC Medical Group Holdings executive stock transactions Form 4 minutes after they post.
- 10-K annual report—our AI delivers a SBC Medical Group Holdings annual report 10-K simplified, highlighting franchise revenue, patient volumes, and equipment capital expenses.
- 8-K disclosures—get SBC Medical Group Holdings 8-K material events explained without combing through legal jargon.
- Proxy statements—instantly surface SBC Medical Group Holdings proxy statement executive compensation details.
Use the platform to compare quarter-over-quarter clinic openings, monitor SBC Medical Group Holdings Form 4 insider transactions real-time, or run an SBC Medical Group Holdings earnings report filing analysis before your next investment decision. With expert commentary layered over AI-powered summaries, understanding SBC Medical Group Holdings SEC documents with AI becomes straightforward—so you can focus on judging growth potential, not parsing footnotes.
SBC Medical Group Holdings Incorporated reported consolidated assets of $315.3 million at June 30, 2025, up from $266.1 million a year earlier, driven by a cash balance of $152.7 million versus $125.0 million at December 31, 2024. For the six months ended June 30, 2025 the company recorded total revenues of $90.69 million, down from $107.91 million a year earlier, with related-party revenues comprising the majority at $84.20 million. Gross profit for the six-month period was $67.74 million and income from operations was $38.76 million, both lower year-over-year.
Net income attributable to SBC for the six months was $23.96 million ($0.23 per share), down from $37.24 million ($0.40 per share). Operating cash flow was an outflow of $6.41 million, offset by investing proceeds of $15.40 million largely from life insurance redemptions and financing inflows of $6.90 million, leaving ending cash higher. Key balance-sheet items include finance lease receivables of $22.33 million, long-term investments of $3.59 million, long-term investments in related MCs of $19.38 million, and 5 Bitcoins held at $535,882 fair value.
SBC Medical Group Holdings Incorporated furnished a press release and an investor presentation reporting results for the quarter ended June 30, 2025. The press release is included as Exhibit 99.1 and the investor presentation as Exhibit 99.2, with the presentation available on the company website at https://sbc-holdings.com/en/ir/ir-presentation. The report specifies these items are furnished, not filed under the Exchange Act and therefore are not subject to Section 18 liabilities. The company identifies as an emerging growth company and lists its common stock (SBC) and redeemable warrants (SBCWW) on The Nasdaq Stock Market LLC.
FAQ
What is the current stock price of SBC Medical Group Holdings Incorporated (SBC)?
What is the market cap of SBC Medical Group Holdings Incorporated (SBC)?
